Literature DB >> 3624209

Cocaine abuse and adult attention deficit disorder.

J A Cocores, R K Davies, P S Mueller, M S Gold.   

Abstract

Cocaine increases dopaminergic tone in the central nervous system, and hyperprolactinemia has been found in chronic cocaine abusers. Dopamine depletion is believed to result from chronic cocaine abuse. Dopamine deficiency has also been associated with attention deficit disorder (ADD) in adults, and dopamine agonists have been effective in the treatment of ADD. Four case reports of cocaine addiction and ADD are presented. ADD was assumed to play an etiologic role in cocaine abuse, and it was postulated that the patients might in part have been self-medicating a dopamine-deficient state. In addition, cocaine addicts without a premorbid history of ADD may experience a temporary cocaine-induced ADD state. In both cases, the dopamine agonist bromocriptine was highly effective for treating ADD and promoting cocaine abstinence. Restoration of the presumed dopamine deficit may permit an easier course of rehabilitation by improving the patient's ability to participate in therapeutic programs.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3624209

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  4 in total

1.  Psychometric vs. attentional correlates of early onset alcohol and substance abuse.

Authors:  D L Pogge; J Stokes; P D Harvey
Journal:  J Abnorm Child Psychol       Date:  1992-04

2.  Drowning the pain: intimate partner violence and drinking to cope prospectively predict problem drinking.

Authors:  Camilla S Øverup; Angelo M DiBello; Julie A Brunson; Linda K Acitelli; Clayton Neighbors
Journal:  Addict Behav       Date:  2014-10-30       Impact factor: 3.913

3.  Formulation and evaluation of 4-benzylpiperidine drug-in-adhesive matrix type transdermal patch.

Authors:  Sindhu S Ganti; Sonalika A Bhattaccharjee; Kevin S Murnane; Bruce E Blough; Ajay K Banga
Journal:  Int J Pharm       Date:  2018-08-17       Impact factor: 5.875

Review 4.  Pharmacological and clinical dilemmas of prescribing in co-morbid adult attention-deficit/hyperactivity disorder and addiction.

Authors:  José Pérez de los Cobos; Núria Siñol; Víctor Pérez; Joan Trujols
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.